Serum KL-6 as a diagnostic and prognostic biomarker in inflammatory myopathies-associated interstitial lung disease: A single-centre prospective cohort study
Publication date: November 2026 Source: Medicina Clínica, Volume 166, Issue 11 Author(s): Jorge Álvarez-Troncoso, Samuel Díaz-Planellas, Luis Gómez-Carrera, María Fernández-Velilla, Clara Soto-Abánades, Elena Martínez-Robles, Juan José Ríos-Blanco
Serum KL-6 as a diagnostic and prognostic biomarker in inflammatory myopathies-associated interstitial lung disease: A single-centre prospective cohort study. // Medicina Clínica. – URL: https://www.sciencedirect.com/science/article/pii/S0025775326002897?dgcid=rss_sd_all
Serum KL-6 as a diagnostic and prognostic biomarker in inflammatory myopathies-associated interstitial lung disease: A single-centre prospective cohort study. Medicina Clínica. https://www.sciencedirect.com/science/article/pii/S0025775326002897?dgcid=rss_sd_all
“Serum KL-6 as a diagnostic and prognostic biomarker in inflammatory myopathies-associated interstitial lung disease: A single-centre prospective cohort study.” Medicina Clínica.
@article{article101030,
title = {Serum KL-6 as a diagnostic and prognostic biomarker in inflammatory myopathies-associated interstitial lung disease: A single-centre prospective cohort study},
journal = {Medicina Clínica},
url = {https://www.sciencedirect.com/science/article/pii/S0025775326002897?dgcid=rss_sd_all}
}
ABSTRACT As leadership education continues to evolve, increasing attention has been given to fostering learners’ leadership identity, capacity, and efficacy. Drawing on collaborative conversations with 12 leadership educators...